m+Medelevator.RU
← Поиск публикаций
Frontiers in microbiology · 2025

Bibliometric analysis of sepsis and gut microbiota: Trends from 2014 to 2024.

СтатьяСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhang Runze, Huo Chenxing, He Chenming, Luo Jielian, Shan Yunan, Lu Jiamin, Zhang Jirong, Zhang Wen, Fang Bangjiang

Аннотация

BACKGROUND: Sepsis is a life-threatening condition characterized by organ dysfunction resulting from a dysregulated host response to infection, with pathological mechanisms closely linked to imbalances in the intestinal flora. While the gut microbiota influences sepsis progression through metabolic and immune regulation, systematic analyses of research trends remain limited. This bibliometric study comprehensively evaluates the sepsis and gut microbiota field from 2014 to 2024.

METHODS: We analyzed 944 English-language articles from the Web of Science (WOS) Core Collection using CiteSpace, VOSviewer, and other software tools. The bibliometric assessments included analysis of publication trends, collaborative networks, geographic distributions, journal impact, and keyword clustering.

RESULTS: A total of 944 publications included contributions from 5,901 authors across 69 countries. These works were published in 405 journals, and cited a total of 45,932 references. The focus of research has transitioned from early topics such as "necrotizing enterocolitis" and "premature infants" to more recent interests on "short-chain fatty acids" (SCFAs) and "Candida albicans." Futhermore, emerging topics include "sepsis-associated encephalopathy," with microbiology and critical care medicine identified as interdisciplinary core fields.

CONCLUSION: The therapeutic potential of the gut microbiota in sepsis is increasingly recognized. Future research should prioritize microbial-targeted therapies, immune-barrier-metabolic network regulation, and integrated traditional Chinese-Western medicine approaches.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты